Home / Contributors / Graham Emslie

Graham Emslie, M.D.

Dr. Emslie's research interests are in the areas of conducting efficacy and effectiveness trials with medications and psychotherapy for children and adolescents with depression, anxiety disorders, and attention-deficit disorder. He is also involved with developing and evaluating medication algorithm protocols for children and adolescents with depression.

Positions

  • Charles E. and Sarah M. Seay Chair in Child Psychiatry, University of Texas Southwest Medical Center

 

Education

  • M.D., 1974, Aberdeen University

 

Relevant Publications

  • Emslie, G. J., Kennard, B., Mayes, T., Nightingale-Teresi, J., Carmody, T., Hughes, C., et al. (2008). Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. American Journal of Psychiatry, 165(4), 459-467.
  • Emslie, G. J., Waslick, B., Weller, E., Kloos, A., Weller, R., & Kratochvil, C. (2007). Antidepressant management in the context of suicidal ideation. Journal of the American Academy of Child & Adolescent Psychiatry, 46(9), 1222-1225.
  • Emslie, G. J., Findling, R., Yeung, P., Kunz, N., & Li, Y. (2007). Venlafaxine ER for the treatment of pediatric subjects with depression: Results of two placebo-controlled trials. Journal of the American Academy of Child & Adolescent Psychiatry, 46(4), 479-488.
  • Hughes, C. W., Emslie, G. J., Wohlfahrt, H., Winslow, R., Kashner, T. M., & Rush, A. J. (2005). Effect of structured interviews on evaluation time in pediatric community mental health settings. Psychiatric Services, 56, 1098-1103.
  • Emslie, G. J, Ryan, N. D., & Wagner, K. D. (2005). Major depressive disorder in children and adolescents: Clinical trial design and antidepressant efficacy. Journal of Clinical Psychiatry, 66(Suppl. 7), 14-20.

 

Contributed Content